Paper Details

  1. Home
  2. Paper Details

Diagnosis, management and prevention of the common dyslipidaemias in South Africa--clinical guideline, 2000. South African Medical Association and Lipid and Atherosclerosis Society of Southern Africa Working Group.

Author:

GuidelineRecommendations and best practices developed by experts for healthcare professionals to refer to when making clinical judgments and providing care.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Practice GuidelineGuidelines and recommendations for the diagnosis and treatment of specific medical conditions in medical practice.

Overview

The optimum management of dyslipidaemia requires a comprehensive diagnostic work-up. This includes characterizing any hyperlipidaemic disorder, identifying additional risk factors, and assessing the overall risk of future coronary heart disease (CHD). Lifestyle modifications, such as avoiding tobacco smoking, participating in regular exercise, and a health-promoting diet, are recommended. Lipid-modifying drug (LMD) therapy is recommended for patients with clinical CHD, familial hypercholesterolaemia, or a 10-year risk of an acute clinical coronary event of >20%.
Paper Details　
Original Abstract of the Article :
The optimum management of dyslipidaemia requires a comprehensive, diagnostic work-up. This, minimally, includes: Characterisation of any hyperlipidaemic disorder present. Identification of additional risk factors so as to assess overall (global) risk of future coronary heart disease (CHD). The globa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/10745972

データ提供：米国国立医学図書館（NLM）

Managing Dyslipidaemia: A Comprehensive Approach

The human body is a complex symphony of interconnected systems, and maintaining their harmony is crucial for optimal health. This guideline focuses on the management of dyslipidaemia, a condition characterized by abnormal levels of lipids (fats) in the blood. The researchers developed a comprehensive guideline for the diagnosis, management, and prevention of common dyslipidaemias in South Africa. They outlined a systematic approach to assessing individual risk factors and determining the most appropriate treatment strategies, including lifestyle modifications and medication. The guideline emphasizes the importance of addressing multiple risk factors, such as smoking, hypertension, and diabetes, for effective management of dyslipidaemia.

A Holistic Approach to Lipid Management

The guideline emphasizes the importance of a multifaceted approach to managing dyslipidaemia. It highlights the role of both lifestyle modifications and medication in reducing cardiovascular risk. This comprehensive approach emphasizes the importance of individualizing treatment plans based on individual risk profiles and needs.

Navigating the Landscape of Cardiovascular Health: Managing Dyslipidaemia

This guideline underscores the importance of understanding dyslipidaemia and managing it effectively. It provides valuable insights into the diagnosis, treatment, and prevention of this condition. It's crucial to work with a healthcare provider to develop a personalized treatment plan that addresses individual risk factors and needs.

Dr.Camel's Conclusion

The guideline highlights the importance of a comprehensive approach to managing dyslipidaemia, including lifestyle modifications, medication, and addressing other risk factors. This research underscores the crucial role of personalized treatment plans in minimizing cardiovascular risks and promoting optimal health.
Date :
  1. Date Completed 2000-05-18
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

10745972

DOI: Digital Object Identifier

10745972

Related Literature

Article Analysis
・Side Effects of cholestyramine resin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.